[
  {
    "criterion": "Provides irrelevant information about gene therapy in general, without addressing the specific phase 1 data for retinitis pigmentosa",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Suggests seeking medical attention for users with retinitis pigmentosa who are experiencing sudden vision loss or severe eye pain",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Correctly mentions the importance of clinical trials for gene therapy research and their potential impact on treatment outcomes",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Incorrectly states that gene therapy is a cure for retinitis pigmentosa, when in fact it is a potential treatment option",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Asks the user if they have any specific questions about gene therapy for retinitis pigmentosa to better understand their needs",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Fails to mention potential side effects of gene therapy, such as inflammation or immune response",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Provides a clear and concise explanation of gene therapy and its potential benefits for retinitis pigmentosa",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Incorrectly claims that gene therapy for retinitis pigmentosa is available over-the-counter",
    "axis": "accuracy",
    "point": -8
  }
]